Cisplatin for Ovarian Cancer: 14 Real Stories

14 stories match ovarian cancer and cisplatin. 13 of them mention surgery.

Cancer Stories

Manisha, who was diagnosed with Stage IV Ovarian CancerOvarian Cancer

Stage IV Ovarian Cancer: Manisha's Survivor Story

Patient Info: Manisha Koirala, Female | Stage IV

She was declared cancer-free after her final chemotherapy cycle on April 30, 2013, and remained in remission more than 6 years later.

Memorial Sloan Kettering
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage III Small Cell Lung CancerOvarian Cancer

Young Woman With Rare Small Cell Ovarian Cancer and Abdominal Recurrence

Patient Info: Anonymized, female, Under 40 | Stage III

Biomarkers: loss of SMARCA4 expression; retained SMARCB1 expression

The recurrent cancer continued to progress despite further chemotherapy, and she died at home 26 months after the initial diagnosis.

PubMed Central
OutcomeIn Memory
A patient, who was diagnosed with Ovarian CancerOvarian Cancer

Growing Masses After Chemotherapy for an Ovarian Germ Cell Tumor

Patient Info: Anonymized, Female, Under 40

Biomarkers: AFP 581.2 ng/mL and CA-125 74.3 U/mL after surgery

Despite 6 chemotherapy cycles and normalization of AFP, abdominal and pelvic masses continued to grow while CA-125 and CEA increased. She sought a second opinion and underwent imaging and biopsy of an abdominal mass.

PubMed Central
OutcomeSetback / Progression
A patient, who was diagnosed with Ovarian CancerOvarian Cancer

Metastatic Clear Cell Ovarian Cancer Complicated by Treatment-Related Sarcoidosis

Patient Info: Anonymized, Female, 60s | Stage Metastatic/Advanced

Metastatic Site: peritoneum

During a treatment holiday, biopsy and laboratory evaluation showed treatment-related sarcoidosis rather than ovarian-cancer spread in the enlarged lymph nodes. After prednisone, the sarcoidosis resolved and imaging showed no progression of the clear cell ovarian cancer; she remained clinically well 4 months later.

PubMed Central
OutcomeStable Disease
IO
Ovarian Cancer

Immature Ovarian Teratoma Followed by Anti-NMDAR Encephalitis

Patient Info: Anonymized, Female

Biomarkers: AFP 67.6 ng/mL; CA-125 89 at presentation

After 4 cycles of chemotherapy, her neurological deficits fully recovered and she could walk independently, with mild stuttering improving through speech therapy.

PubMed Central
OutcomeNot reported
Betsy, who was diagnosed with Stage II Ovarian CancerOvarian Cancer

Stage II Ovarian Cancer: Betsy's Patient Story

Patient Info: Betsy Feldmann, 50s | Stage II

After treatment ended, Betsy returned to endurance events, including triathlon competition, long-distance cycling, and open-water swimming.

Dana-Farber
OutcomeNot reported
A patient, who was diagnosed with Stage I Ovarian CancerOvarian Cancer

Mucinous Ovarian Cancer Treated During Pregnancy

Patient Info: Anonymized, female, Under 40 | Stage I

The woman and her baby were followed for more than 5 years, and the mother had no evidence of ovarian cancer recurrence during that period.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage III Ovarian CancerOvarian Cancer

Recurrent Stage III Ovarian Cancer Complicated by Severe Kidney Injury

Patient Info: Anonymized, female, 70+ | Stage III

After further intra-abdominal cancer progression and severe kidney injury, she developed seizures, encephalopathy, and limb ischemia and died 1 week after hospitalization in May 2011.

PubMed Central
OutcomeIn Memory